Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group (Q46502896)
Jump to navigation
Jump to search
scientific article published in May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group |
scientific article published in May 2005 |
Statements
1 reference
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group (English)
1 reference
Susan M Blaney
1 reference
Paul Gaynon
1 reference
Joanne Kurtzberg
1 reference
Stacey L Berg
1 reference
Meenakshi Devidas
1 reference
Tom A Lampkin
1 reference
Anthony Murgo
1 reference
Mark Bernstein
1 reference
Amy Billett
1 reference
Greg Reaman
1 reference
James Whitlock
1 reference
Mark Krailo
1 reference
Michael B Harris
1 reference
Children's Oncology Group
1 reference
1 May 2005
1 reference
23
1 reference
15
1 reference
3376-3382
1 reference